Citius Pharmaceuticals Inc. (NASDAQ:CTXR) and Intec Pharma Ltd. (NASDAQ:NTEC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.
Table 1 demonstrates Citius Pharmaceuticals Inc. and Intec Pharma Ltd.’s top-line revenue, earnings per share (EPS) and valuation.
Table 2 hightlights the return on equity, net margins and return on assets of the two companies.
Institutional Insider Ownership
Citius Pharmaceuticals Inc. and Intec Pharma Ltd. has shares owned by institutional investors as follows: 4.2% and 40.23%. 42.8% are Citius Pharmaceuticals Inc.’s share owned by insiders. Comparatively, Intec Pharma Ltd. has 16.08% of it’s share owned by insiders.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year Citius